Natera Inc News - NTRA | ADVFN

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Natera Inc (NTRA)

110.37

0.00

(0.00%)

Closed July 18 4:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Form 4 - Statement of changes in beneficial ownership of securities

FeaturedNightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com

Form 144 - Report of proposed sale of securities

Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that its latest research and data on...

Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer

First-of-its-kind study in gastroesophageal adenocarcinoma using Signatera to guide treatment and assess the efficacy of a novel HER2-directed...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 144 - Report of proposed sale of securities

Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients

Donor Quantity Score (DQS) technique is unique to Natera, improving detection of both acute cellular rejection and antibody-mediated rejection...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will present at the Goldman Sachs 45th...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

1
Next

Monksdream

Monksdream 1 month ago

Pioneers in individualized genetic testing

Cell-free DNA (cfDNA) can be found in everyone. Not only do our own cells release it, so do fetal, tumor, and donor organ cells. Using a simple blood draw, our technology precisely detects each of these types of cell-free DNA, uniquely for each individual, to help proactively inform their treatment.
With more than 15 years of experience focused in this field, our technology has been used to perform more cell-free DNA tests than any other.

Monksdream

Monksdream 4 months ago

NTRA new 52 week high

Monksdream

Monksdream 5 months ago

NTRA new 52 week high

Delayed Upgrade Clock